Moderna did not reply to Reuters' request for comment on the interview and on when it expects to have data on the effectiveness of its vaccine against Omicron, which the World Health Organization (WHO) says carries a "very high" risk of infection surges.
from Top World News- News18.com https://ift.tt/3lm6BFA
https://ift.tt/eA8V8J
0 Comments